Cargando…

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer

Multiple studies showed the prognostic capacities of tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancer (TNBC), but not in other subtypes. We evaluated tumor expression of FAS, a key receptor in T-cell mediated apoptosis, as possible explanation for this differential prognostic v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blok, Erik J., van den Bulk, Jitske, Dekker-Ensink, N. Geeske, Derr, Remco, Kanters, Corné, Bastiaannet, Esther, Kroep, Judith R., van de Velde, Cornelis J.H., Kuppen, Peter J.K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362509/ https://www.ncbi.nlm.nih.gov/pubmed/28121628 http://dx.doi.org/10.18632/oncotarget.14779

Ejemplares similares

High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
por: Derr, Remco S, et al.
Publicado: (2014)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
por: de Groot, A. F., et al.
Publicado: (2019)

Sialyl Lewis X Expression and Lymphatic Microvessel Density in Primary Tumors of Node-negative Colorectal Cancer Patients Predict Disease Recurrence
por: Doekhie, Fania S., et al.
Publicado: (2008)

Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
por: Blok, Erik J, et al.
Publicado: (2013)

Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer
por: de Muijnck, Cansu, et al.
Publicado: (2020)

Clinical impact of HLA class I expression in rectal cancer
por: Speetjens, Frank M., et al.
Publicado: (2007)

Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer
por: Mieog, J Sven D, et al.
Publicado: (2012)

Fas Ligand (FasL) in Association with Tumor-Infiltrating Lymphocytes (TILs) in Early Stage Cervical Cancer
por: Anggraeni, Tricia Dewi, et al.
Publicado: (2020)

Biomarkers in precision therapy in colorectal cancer
por: Reimers, Marlies S., et al.
Publicado: (2013)

Revising the Role of Integrin Subunit β4 Expression in Colon Cancer Progression and Survival
por: Rademaker, Eva, et al.
Publicado: (2022)

A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
por: Engels, Charla C., et al.
Publicado: (2016)

Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
por: Reimers, Marlies S, et al.
Publicado: (2014)

The Prognostic Value of the Apoptosis Pathway in Colorectal Cancer: A Review of the Literature on Biomarkers Identified by Immunohistochemistry
por: Zeestraten, Eliane C.M., et al.
Publicado: (2013)

Fas and the art of lymphocyte maintenance
Publicado: (1996)

Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients
por: Speetjens, Frank M., et al.
Publicado: (2008)

Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer
por: Swets, Marloes, et al.
Publicado: (2016)

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes
por: Sobral-Leite, Marcelo, et al.
Publicado: (2019)

Expression of uPAR in tumor-associated stromal cells is associated with colorectal cancer patient prognosis: a TMA study
por: Boonstra, Martin C, et al.
Publicado: (2014)

Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer
por: Benard, Anne, et al.
Publicado: (2014)

FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer
por: Zeestraten, Eliane C. M., et al.
Publicado: (2011)

Cancer immunotherapy: broadening the scope of targetable tumours
por: van den Bulk, Jitske, et al.
Publicado: (2018)

Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins
por: Boonstra, Martin C., et al.
Publicado: (2016)

Copy number alterations and allelic ratio in relation to recurrence of rectal cancer
por: Goossens-Beumer, Inès J, et al.
Publicado: (2015)

Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing
por: Suda, Takashi, et al.
Publicado: (1997)

T Cell–specific Ablation of Fas Leads to Fas Ligand–mediated Lymphocyte Depletion and Inflammatory Pulmonary Fibrosis
por: Hao, Zhenyue, et al.
Publicado: (2004)

Fas transduces activation signals in normal human T lymphocytes
Publicado: (1993)

A Novel Gene Coding for a Fas Apoptosis Inhibitory Molecule (FAIM) Isolated from Inducibly Fas-resistant B Lymphocytes
por: Schneider, Thomas J., et al.
Publicado: (1999)

Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
por: van den Bulk, Jitske, et al.
Publicado: (2021)

Maximal Proliferation of Cytotoxic T Lymphocytes Requires Reverse Signaling through Fas Ligand
por: Suzuki, Ivy, et al.
Publicado: (1998)

NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
por: de Kruijf, Esther M, et al.
Publicado: (2012)

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway
por: Konkankit, Veerauo V, et al.
Publicado: (2011)

Overexpression of Fas and FasL Is Associated with Infectious Complications and Severity of Experimental Severe Acute Pancreatitis by Promoting Apoptosis of Lymphocytes
por: Pinhu, Liao, et al.
Publicado: (2014)

Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis
por: Owen-Schaub, Laurie B., et al.
Publicado: (1998)

Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells
por: de Geus, Susanna WL, et al.
Publicado: (2017)

Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

Fas ligand mediates activation-induced cell death in human T lymphocytes
Publicado: (1995)

Sublingual immunotherapy in asthma does not influence lymphocyte sensitivity to fas stimulation
por: Ciepiela, O, et al.
Publicado: (2010)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL
por: Rikhof, B, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8us752t586aukck86do6tkahrp